| Dr Kevin A Vohs, PHARM D | |
|
100 Crestview Cir Ste 120, Louisburg, KS 66053-6472 | |
| (913) 533-7575 | |
| (888) 546-0706 |
| Full Name | Dr Kevin A Vohs |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 100 Crestview Cir Ste 120, Louisburg, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386739423 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13656 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin A Vohs, PHARM D 13757 W 247th St, Louisburg, KS 66053-5923 Ph: (913) 533-7575 | Dr Kevin A Vohs, PHARM D 100 Crestview Cir Ste 120, Louisburg, KS 66053-6472 Ph: (913) 533-7575 |
News Archive
A normal but concerning consequence of pregnancy is the fact that pregnant women are more susceptible to infection. University of Minnesota Medical School researchers have identified the underlying mechanisms for this physiologic immune suppression that may lead to new therapies to help ward off infections during pregnancy.
Eating a Mediterranean diet appears to be associated with less risk of mild cognitive impairment-a stage between normal aging and dementia-or of transitioning from mild cognitive impairment into Alzheimer's disease, according to a report in the February issue of Archives of Neurology.
The US Department of Health and Human Services and the Critical Care Societies Collaborative have established a new national awards program. The National Awards Program to Recognize Achievements in Eliminating Healthcare-Associated Infections will annually recognize teams of critical care professionals and healthcare institutions that achieve excellence and notable, sustained improvements in preventing healthcare-associated infections, specifically infections in critical care.
Many recent reports have found multidrug resistant bacteria living in hospital sink drainpipes, putting them in close proximity to vulnerable patients.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
› Verified 7 days ago
Dr. Jarratt A Asher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 S Metcalf Rd, Louisburg, KS 66053 Phone: 913-837-5555 | |
Carli Riemer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Crestview Cir Ste 120, Louisburg, KS 66053 Phone: 913-837-3784 Fax: 913-837-3784 | |
Mr. Kerry Donald Mckeever, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 S Metcalf Rd, Louisburg, KS 66053 Phone: 913-837-5555 Fax: 913-837-5569 |